Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IQ motif containing GTPase activating protein 1 (IQGAP1) mRNA is the transcript encoding a versatile scaffold protein that integrates multiple intracellular signaling pathways, including the MAPK, PI3K/Akt, and Wnt/beta-catenin cascades (UniProt P46940). The encoded IQGAP1 protein plays a critical role in regulating the actin cytoskeleton, cell-cell adhesion, and cell migration by interacting with Rho GTPases like Cdc42 and Rac1 (PMID: 24608501). In many human malignancies, such as breast, lung, and liver cancer, IQGAP1 is significantly overexpressed and correlates with increased tumor aggressiveness, metastasis, and poor clinical outcomes (PMID: 30107118). Targeting the IQGAP1 mRNA using RNA interference (RNAi) or antisense oligonucleotides (ASOs) aims to deplete the protein levels, thereby disrupting the oncogenic signaling networks it supports (PMID: 28656238). Preclinical studies have demonstrated that silencing IQGAP1 mRNA can inhibit cancer cell proliferation, reduce invasion, and sensitize tumors to existing chemotherapies (PMID: 25533318). While currently in the preclinical stage, this approach represents a promising strategy for precision oncology and potentially for treating inflammatory conditions where IQGAP1-mediated signaling is dysregulated.
The primary mechanism of action for drugs targeting IQGAP1 mRNA is RNA interference (RNAi) or antisense-mediated degradation, which leads to the knockdown of IQGAP1 protein levels and subsequent disruption of oncogenic signaling scaffolds (PMID: 24608501, PMID: 28656238).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IQ motif containing GTPase activating protein 1 mRNA (IQGAP1 mRNA).